Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 16, 2012
[A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel]
Kiichiro Ninomiya, Tomohiko Mannami, Satoru Seno, et al.
Immunologic Research
|
June 13, 2019
Catalase expression of Propionibacterium acnes may contribute to intracellular persistence of the bacterium in sinus macrophages of lymph nodes affected by sarcoidosis
Kurara Yamamoto, Keisuke Uchida, Asuka Furukawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 27, 2016
[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report]
Satoru Senoo, Tomohiko Mannami, Tomoki Tamura, et al.
Respiratory Investigation
|
October 4, 2024
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance status
Kazuhisa Nakashima, Hiroaki Kodama, Haruyasu Murakami, et al.
Cureus
|
July 24, 2025
Retreatment With EGFR-Tyrosine Kinase Inhibitor After Disease Progression Following Gefitinib Induction and Chemoradiotherapy in EGFR-Mutant Stage III Non-small Lung Cancer: An Efficacy and Safety Analysis of the LOGIK0902/OLCSG0905 Study
Sho Saeki, Katsuyuki Hotta, Shinya Sakata, et al.
Cancers
|
December 23, 2022
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study
Tomoka Nishimura, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology
|
August 28, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy
Nobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology
|
May 9, 2022
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801
Shinobu Hosokawa, Eiki Ichihara, Daijiro Harada, et al.
Plos One
|
February 6, 2018
Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis
Yoshimi Suzuki, Keisuke Uchida, Tamiko Takemura, et al.
Journal of Cancer Research and Clinical Oncology
|
October 29, 2022
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance
Chihiro Ando, Eiki Ichihara, Toshihide Yokoyama, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 16, 2012
[A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel]
Kiichiro Ninomiya, Tomohiko Mannami, Satoru Seno, et al.
Immunologic Research
|
June 13, 2019
Catalase expression of Propionibacterium acnes may contribute to intracellular persistence of the bacterium in sinus macrophages of lymph nodes affected by sarcoidosis
Kurara Yamamoto, Keisuke Uchida, Asuka Furukawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 27, 2016
[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report]
Satoru Senoo, Tomohiko Mannami, Tomoki Tamura, et al.
Respiratory Investigation
|
October 4, 2024
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance status
Kazuhisa Nakashima, Hiroaki Kodama, Haruyasu Murakami, et al.
Cureus
|
July 24, 2025
Retreatment With EGFR-Tyrosine Kinase Inhibitor After Disease Progression Following Gefitinib Induction and Chemoradiotherapy in EGFR-Mutant Stage III Non-small Lung Cancer: An Efficacy and Safety Analysis of the LOGIK0902/OLCSG0905 Study
Sho Saeki, Katsuyuki Hotta, Shinya Sakata, et al.
Cancers
|
December 23, 2022
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study
Tomoka Nishimura, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology
|
August 28, 2025
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy
Nobuaki Ochi, Eiki Ichihara, Toshihide Yokoyama, et al.
International Journal of Clinical Oncology
|
May 9, 2022
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801
Shinobu Hosokawa, Eiki Ichihara, Daijiro Harada, et al.
Plos One
|
February 6, 2018
Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis
Yoshimi Suzuki, Keisuke Uchida, Tamiko Takemura, et al.
Journal of Cancer Research and Clinical Oncology
|
October 29, 2022
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance
Chihiro Ando, Eiki Ichihara, Toshihide Yokoyama, et al.
Page
of 8